A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Public ClinicalTrials.gov record NCT06809595. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40 Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults With Generalized Anxiety Disorder - Panorama
Study identification
- NCT ID
- NCT06809595
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Definium Therapeutics US, Inc.
- Industry
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Interventions
- MM120 (LSD D-Tartrate) Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2025
- Primary completion
- Oct 31, 2026
- Completion
- Apr 30, 2027
- Last update posted
- Apr 30, 2026
2025 – 2027
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Preferred Research Partners, Inc. | Little Rock | Arkansas | 72211 | — |
| Psychedelic Science Institute | Los Angeles | California | 90004 | — |
| West Los Angeles VA Medical Center | Los Angeles | California | 90073 | — |
| Bradenton Research Center, Inc. | Bradenton | Florida | 34205 | — |
| Clinical Neuroscience Solutions, Inc | Orlando | Florida | 32801 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| Sheppard Pratt Health System | Towson | Maryland | 21204 | — |
| Adams Clinical Boston | Boston | Massachusetts | 02116 | — |
| Princeton Medical Institute | Princeton | New Jersey | 08540 | — |
| University of Cincinnati Psychiatry- Anxiety Disorders Research Program | Cincinnati | Ohio | 45219 | — |
| Neuro-Behavioral Clinical Research, Inc. | North Canton | Ohio | 44720 | — |
| Austin Clinical Trial Partners | Austin | Texas | 78737 | — |
| Cedar Clinical Research | Murray | Utah | 84107 | — |
| Core Clinical Research | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06809595, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2026 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06809595 live on ClinicalTrials.gov.